scholarly journals Sterol Carrier Protein-2 Directly Interacts with Caveolin-1 in Vitro and in Vivo†

Biochemistry ◽  
2004 ◽  
Vol 43 (23) ◽  
pp. 7288-7306 ◽  
Author(s):  
Minglong Zhou ◽  
Rebecca D. Parr ◽  
Anca D. Petrescu ◽  
H. Ross Payne ◽  
Barbara P. Atshaves ◽  
...  
Keyword(s):  
Carrier Protein ◽  
Sterol Carrier Protein ◽  
Caveolin 1 ◽  
Sterol Carrier Protein 2

scholarly journals Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes.

1989 ◽  
Vol 108 (4) ◽  
pp. 1353-1361 ◽  
Author(s):  
G A Keller ◽  
T J Scallen ◽  
D Clarke ◽  
P A Maher ◽  
S K Krisans ◽  
...  
Keyword(s):  
Subcellular Localization ◽  
Rat Liver ◽  
Polyclonal Antibodies ◽  
Rat Hepatocytes ◽  
Carrier Protein ◽  
Sterol Carrier Protein ◽  
Rat Liver Cells ◽  
Ultrathin Frozen Sections ◽  
Sterol Carrier Protein 2

Sterol carrier protein-2 (SCP-2) is a nonenzymatic protein of 13.5 kD which has been shown in in vitro experiments to be required for several stages in cholesterol utilization and biosynthesis. The subcellular localization of SCP-2 has not been definitively established. Using affinity-purified rabbit polyclonal antibodies against electrophoretically pure SCP-2 from rat liver, we demonstrate by immunoelectron microscopic labeling of ultrathin frozen sections of rat liver that the largest concentration of SCP-2 is inside peroxisomes. In addition the immunolabeling indicates that there are significant concentrations of SCP-2 inside mitochondria, and associated with the endoplasmic reticulum and the cytosol, but not inside the Golgi apparatus, lysosomes, or the nucleus. These results were confirmed by immunoblotting experiments with proteins from purified subcellular fractions of the rat liver cells carried out with the anti-SCP-2 antibodies. The large concentration of SCP-2 inside peroxisomes strongly supports the proposal that peroxisomes are critical sites of cholesterol utilization and biosynthesis. The presence of SCP-2 inside peroxisomes and mitochondria raises questions about the mechanisms involved in the differential targeting of SCP-2 to these organelles.

Crystallization and initial X-ray analysis of rabbit mature sterol carrier protein 2

1999 ◽  
Vol 55 (8) ◽  
pp. 1478-1480
Author(s):  
Thomas Choinowski ◽  
James H. Dyer ◽  
Bernhard Maderegger ◽  
Kaspar H. Winterhalter ◽  
Helmut Hauser ◽  
...  
Keyword(s):  
Carrier Protein ◽  
Sterol Carrier Protein ◽  
Asymmetric Unit ◽  
Intracellular Protein ◽  
Hanging Drop ◽  
Unit Cell Parameters ◽  
X Ray ◽  
Cell Parameters ◽  
Sterol Carrier Protein 2

Sterol carrier protein 2 (SCP2) is a basic intracellular protein which facilitates the in vitro intermembrane transfer of cholesterol, phospholipids and glycolipids. SCP2 was expressed in Escherichia coli, purified to apparent electrophoretic homogeneity and crystallized. Single crystals were obtained by hanging-drop vapour diffusion using ammonium sulfate as precipitant. These crystals belong to space group P41212 or its enantiomorph, with unit-cell parameters a = b = 57.5, c = 86.5 Å, and have one molecule in the crystallographic asymmetric unit. Intensity data to 1.8 Å resolution were collected from native SCP2 crystals using synchrotron radiation, were processed and scaled with an R linear = 4.9%.

scholarly journals In Vivo Functional Genomic Studies of Sterol Carrier Protein-2 Gene in the Yellow Fever Mosquito

PLoS ONE ◽  
2011 ◽  
Vol 6 (3) ◽  
pp. e18030 ◽  
Author(s):  
Rong Peng ◽  
Vilena I. Maklokova ◽  
Jayadevi H. Chandrashekhar ◽  
Que Lan
Keyword(s):  
Yellow Fever ◽  
Carrier Protein ◽  
Functional Genomic ◽  
Sterol Carrier Protein ◽  
Yellow Fever Mosquito ◽  
Genomic Studies ◽  
Sterol Carrier Protein 2

Expression of sterol carrier protein 2 (SCP2) in human adrenocortical tissue

1996 ◽  
Vol 134 (4) ◽  
pp. 501-507 ◽  
Author(s):  
Toshihiko Yanase ◽  
Takayuki Hara ◽  
Yoshiyuki Sakai ◽  
Ryoichi Takayanagi ◽  
Hajime Nawata
Keyword(s):  
Free Cholesterol ◽  
In Vitro Studies ◽  
Carrier Protein ◽  
Northern Blot Hybridization ◽  
Sterol Carrier Protein ◽  
Adrenocortical Adenomas ◽  
Adrenocortical Carcinomas ◽  
Tissue Specimens ◽  
Sterol Carrier Protein 2

Yanase T, Hara T, Sakai Y, Takayanagi R, Nawata H. Expression of sterol carrier protein 2 (SCP2) in human adrenocortical tissue. Eur J Endocrinol 1996;134:501–7. ISSN 0804–4643 Sterol carrier protein 2 (SCP2) has been implicated in adrenal steroidogenesis by in vitro studies. In order to clarify the clinical significance of SCP2 in human steroidogenesis, we investigated the expression of SCP2 mRNA in various types of adrenocortical tissue and one testis and examined the correlation between the amounts of SCP2 and other values such as the free cholesterol content and the cholesterol side-chain cleavage (SCC) activity in the tissue mitochondria, The types of adrenocortical tissue examined included adrenocortical carcinomas (N = 3), adrenocortical adenomas from patients with Conn's syndrome (N = 3) and from patients with Cushing's syndrome (N = 3), non-functioning adrenocortical adenomas (N = 2) and normal adrenal glands (N = 2). Northern blot hybridization predominantly revealed a 1.8-kb SCP2 mRNA in all tissue specimens examined. The mRNA concentrations of SCP2 in two out of three adrenocortical carcinomas were relatively lower than those in other types of tissue. No other special tendency was observed regarding the mRNA expression levels in various tissue specimens. The mRNA concentrations of SCP2 correlated significantly with mitochondrial contents of free cholesterol (r = 0.67, p < 0.01), but was not correlated with the SCC activities in mitochondria measured by an in vitro enzyme assay. The mitochondrial SCC activities, however, were correlated significantly with the protein levels of mitochondrial P-450 scc determined by a Western blot analysis (r = 0.79, p < 0.01). The significant positive correlation between mRNA concentrations of SCP2 and the mitochondrial content of free cholesterol suggests that the central role of SCP2 in human steroidogenic tissues may be in part a translocation of cytoplasmic free cholesterol to the mitochondria, as demonstrated previously by in vitro studies. Toshihiko Yanase, Third Department of Internal Medicine, Faculty of Medicine, Maidashi 3-1-1, Higashi-ku, Fukuoka 812, Japan

scholarly journals A New N-Terminal Recognition Domain in Caveolin-1 Interacts with Sterol Carrier Protein-2 (SCP-2)†

Biochemistry ◽  
2007 ◽  
Vol 46 (28) ◽  
pp. 8301-8314 ◽  
Author(s):  
Rebecca D. Parr ◽  
Gregory G. Martin ◽  
Heather A. Hostetler ◽  
Megan E. Schroeder ◽  
Kiran D. Mir ◽  
...  
Keyword(s):  
Carrier Protein ◽  
Sterol Carrier Protein ◽  
Caveolin 1 ◽  
Sterol Carrier Protein 2

scholarly journals Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile

1996 ◽  
Vol 317 (3) ◽  
pp. 681-687 ◽  
Author(s):  
Luigi PUGLIELLI ◽  
Attilio RIGOTTI ◽  
Ludwig AMIGO ◽  
Liliana NUÑEZ ◽  
Aldo V. GRECO ◽  
...  
Keyword(s):  
Time Course ◽  
Molecular Mechanisms ◽  
Cholesterol Gallstone ◽  
The Body ◽  
Biliary Secretion ◽  
Carrier Protein ◽  
Sterol Carrier Protein ◽  
Biliary Cholesterol ◽  
Sterol Carrier Protein 2

Biliary cholesterol represents one of the two major excretory pathways for sterol elimination from the body and plays a central role in cholesterol gallstone formation. Biliary cholesterol originates from a precursor pool of preformed and newly synthesized free cholesterol. Although it has been suggested that newly synthesized and preformed biliary cholesterol are secreted by independent pathways, the specific cellular and molecular mechanisms are unknown. We used male Wistar rats to study the time-course of the appearance of newly synthesized cholesterol, phosphatidylcholine and protein into bile. The specific role of sterol carrier protein-2 (SCP-2) in the transport of newly synthesized biliary cholesterol was evaluated by an in vivo antisense oligonucleotide approach. In contrast to [14C]phosphatidylcholine and [35S]proteins, the time-course of [14C]cholesterol appearance into bile was rapid, and microtubule- and Golgi-independent. In vivo SCP-2 antisense treatment reduced and delayed the appearance of biliary [14C]cholesterol. Furthermore, hepatic SCP-2 expression increased more than 3-fold over control values in rats that had been treated with diosgenin to increase biliary secretion of newly synthesized cholesterol. These results suggest that SCP-2 is necessary for the rapid transport of newly synthesized cholesterol into bile and that hepatocytes can induce SCP-2 expression according to the rate of biliary secretion of newly synthesized cholesterol.

The Inhibition Effect of Caveolin-1 on PANC1 Human Pancreatic Tumor Growth In vitro and In vivo*

2012 ◽  
Vol 38 (12) ◽  
pp. 1121-1131
Author(s):  
Xiao-Hui WANG ◽  
Ya-Min ZHENG ◽  
Ye-Qing CUI ◽  
Shuang LIU ◽  
Hai-Chen SUN ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Pancreatic Tumor ◽  
Caveolin 1 ◽  
Inhibition Effect
Sign in / Sign up

Export Citation Format

Share Document